Monday, January 30, 2006
AtheroGenics clears antitrust hurdle; triggers payout
Drugmaker AtheroGenics Inc.said on Monday it will receive a $50 million payment from AstraZeneca for a licensing agreement after the company cleared an antitrust hurdle.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment